Diabetes Mellitus (Record no. 29195)

MARC details
000 -LEADER
fixed length control field 02411nam a22003017a 4500
001 - CONTROL NUMBER
control field 20241017094432.0
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20241017094843.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 241017b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 978-981-13-3540-2 (eBook)
International Standard Book Number 978-981-13-3539-6
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0065-2598
International Standard Serial Number 2214-8019 (electronic)
040 ## - CATALOGING SOURCE
Transcribing agency ddc
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.462 NAK
100 ## - MAIN ENTRY--PERSONAL NAME
Fuller form of name Yusaku Nakabeppu
245 ## - TITLE STATEMENT
Title Diabetes Mellitus
Remainder of title A risk factor for Alzheimer’s Disease
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience Medical Institute of Bioregulation, Kyushu University Fukuoka, Japan |
Name of publisher, distributor, etc. Springer Nature Singapore Pte Ltd |
Date of publication, distribution, etc. 2019
300 ## - PHYSICAL DESCRIPTION
Extent 247 Pages
Extent Includes References
490 ## - SERIES STATEMENT
Series statement Advances in Experimental Medicine and Biology
520 ## - SUMMARY, ETC.
Summary, etc. <br/>This book describes the precise mechanisms by which insulin resistance and diabetes mellitus (DM) act as risk factors for Alzheimer’s disease (AD). It opens by discussing the de novo synthesis of insulin in the brain and its functional significance with regard to glucose metabolism and maintenance of neuronal function in the brain. The epidemiological evidence that DM is a risk factor for the development of dementia, including AD as well as vascular dementia, is then examined. Subsequent chapters explore in depth the mechanisms involved in this relationship, including abnormal protein processing, dysregulated glucose metabolism, impaired insulin signaling, and mitochondrial dysfunction. The molecular interactions between diabetes and AD are fully discussed, highlighting the pathological molecular mechanisms induced by diabetes that promote and accelerate AD pathology. Finally, diagnostic biomarkers and potential therapeutic approaches for AD are considered on the basis of the presented evidence. In providing answers to the critical questions of whether and why DM is a risk factor for AD, this book will hold appeal for a wide interdisciplinary audience.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Diseases, Medical / Endocrinology & Metabolism, Medical / General, Medical / Neurology, Medical / Neuroscience, Neurology, Neurosciences, Science / Life Sciences / Neuroscience, Alzheimer's disease -- Risk factors, Diabetes.
700 ## - ADDED ENTRY--PERSONAL NAME
Fuller form of name Toshiharu Ninomiya
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/978-981-13-3540-2 ">https://doi.org/10.1007/978-981-13-3540-2 </a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Suppress in OPAC
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Total checkouts Full call number Barcode Date last seen Uniform resource identifier Price effective from Koha item type
          MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO 10/17/2024   616.462 NAK 20241017094432.0 10/17/2024 https://doi.org/10.1007/978-981-13-3540-2 10/17/2024 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024